Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of YSBP vs Lumigan in POAG or OH
NCT07661329Phase 3Recruiting
- Sponsor
- Yonsung Fine Chemicals
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Countries
- 2
01
Overview
A Phase 3 trial of bimatoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Yonsung Fine Chemicals. Started Jun 2026; status: recruiting.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT07661329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07661329.